Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02832115 · ClinicalTrials.gov registry record · Phase 4
Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention
A Phase 4 study, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT02832115 is a Phase 4 study that has completed, run by Aultman Health Foundation. The registered enrollment target is 100 participants.
The verdict
NCT02832115, a Phase 4 study, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
The primary objective of the study is to determine the role of transdermal vasodilators as an adjunct to parenteral vasodilators in reducing radial artery spasm, improving patient comfort, and post procedure radial artery patency during transradial coronary angiograms and interventions. The study hypothesis is that transdermal vasodilators will increase radial artery size and reduce radial artery spasm as well as improve patient comfort and post procedure radial artery patency. This is a single-center, double-blind, randomized, placebo-controlled study comparing the effect of transdermal preparations of lidocaine + nitroglycerine and lidocaine + placebo on radial artery spasm in patients undergoing transdermal coronary angiograms. Prior to the procedure, each patient will be randomized into either the control arm, lidocaine + placebo, or study arm, lidocaine + nitroglycerine.
Interventions
- DRUG Topical Nitroglycerine
- DRUG Topical Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-05-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02832115
The ClinicalTrials.gov registry entry for NCT02832115 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical Nitroglycerine is the first listed.
NCT02832115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02832115 about?
NCT02832115 is a clinical study titled "Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention". The primary objective of the study is to determine the role of transdermal vasodilators as an adjunct to parenteral vasodilators in reducing radial artery spasm, improving patient comfort, and post procedure radial artery patency during transradial coronary angiograms and interventions. The study hy...
What is the current status of trial NCT02832115?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2016-09. Estimated completion is 2019-05-02.
What interventions are being tested in trial NCT02832115?
The interventions under investigation include: Topical Nitroglycerine (DRUG), Topical Lidocaine (DRUG).
Who is sponsoring clinical trial NCT02832115?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.